Qiagen, Exosome Diagnostics Partner to Develop Sample Prep Kits | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen and Exosome Diagnostics have inked a partnership to develop and commercialize co-branded kits to capture and process RNA and DNA from biofluid exosomes and other microvesicles, the companies said after the markets closed on Tuesday.

As part of the agreement, the companies will combine Exosome's proprietary exosome platform technology with select Qiagen consumables and automation platforms, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.